How to Administer Salbutamol Nebulization
Administer salbutamol 2.5–5 mg nebulized in adults and 0.15 mg/kg (minimum 2.5 mg) in children, diluted to a minimum of 3–4 mL with normal saline, driven by oxygen at 6–8 L/min for acute asthma or compressed air for COPD, repeated every 20 minutes for three doses, then every 4–6 hours as needed. 1, 2, 3
Equipment Setup and Preparation
Nebulizer Configuration
- Use a jet nebulizer with either a mouthpiece or face mask depending on patient preference and clinical status 1
- Mouthpieces are theoretically superior as they avoid nasal deposition, though breathless patients often prefer face masks and clinical outcomes are equivalent 1
- Ensure the nebulizer system has a residual volume <1.0 mL; if residual volume exceeds this, dilute the drug to a minimum total volume of 4 mL with 0.9% sodium chloride 1
Driving Gas Selection
- For acute asthma: use oxygen at 6–8 L/min as the driving gas to simultaneously treat bronchospasm and hypoxemia 1, 3
- For COPD exacerbations: use compressed air (not oxygen) to prevent worsening CO₂ retention and respiratory acidosis 1, 3
- If COPD patients require supplemental oxygen during air-driven nebulization, provide low-flow oxygen (1–4 L/min) via nasal cannulae simultaneously 3, 4
Dosing Protocols
Adults
Acute Asthma
- Initial dose: 2.5–5 mg salbutamol (or 5–10 mg terbutaline) 1
- Repeat every 20 minutes for the first hour (three doses total) 1, 3
- After initial three doses, continue every 4–6 hours as needed based on clinical response 1
- Add ipratropium bromide 500 µg to each nebulization if poor initial response or severe presentation 1
COPD Exacerbations
- Dose: 2.5–5 mg salbutamol (or 5–10 mg terbutaline) 1
- Administer every 4–6 hours 1
- Adding ipratropium provides no additional benefit in acute COPD exacerbations (unlike in asthma) 1
Children
Pediatric Dosing
- Weight-based: 0.15 mg/kg salbutamol (or 0.3 mg/kg terbutaline) with a mandatory minimum of 2.5 mg regardless of weight 1, 2
- For acute severe asthma: repeat every 20 minutes for three doses, then every 1–4 hours as needed 1, 2
- Add ipratropium bromide 250 µg (half the adult dose) if moderate-to-severe distress after initial treatment 1, 2
Alternative MDI-Spacer Approach (Preferred When Feasible)
- MDI with spacer and face mask is the recommended first-line delivery method for infants and children, offering comparable efficacy while being more economical 2
- Give 2 puffs (180 µg total) via MDI-spacer-mask every 20 minutes for three doses; up to 20 puffs cumulative may be used in severe cases 2
Administration Technique
Nebulization Process
- Nebulize until approximately one minute after "spluttering" occurs, typically 5–10 minutes total 1
- Never use "dryness" as an endpoint for stopping treatment 1
- Instruct patients to tap the nebulizer cup toward the end of treatment to mobilize remaining medication 1
- Set an upper time limit for treatment (typically 10 minutes maximum) 1
Patient Positioning and Interface
- Use face masks for acutely breathless patients, infants, and those unable to hold a mouthpiece 3
- Use mouthpieces when administering ipratropium to elderly patients to avoid ocular complications and glaucoma risk 1, 3
Monitoring and Safety
Clinical Assessment
- Measure peak expiratory flow before and after each treatment 3
- Monitor for β-adrenergic side effects: tachycardia, tremor, palpitations (though uncommon with inhaled therapy) 2, 3
- First treatment should always be supervised, especially in elderly patients who may develop angina 1
Escalation Criteria
- Lack of response to repeated nebulized therapy indicates need for senior clinician review and consideration of additional interventions 1
- For refractory severe asthma, consider continuous nebulization at 0.5 mg/kg/hour (maximum 10–15 mg/hour) in intensive care settings 3, 4
- Add systemic corticosteroids (oral prednisolone 2 mg/kg/day for 3 days in children, maximum 40 mg/day) for moderate-to-severe exacerbations 2
Critical Pitfalls to Avoid
- Never drive nebulizers with oxygen in COPD patients with CO₂ retention without monitoring arterial blood gases 3, 4
- Never use compressed air or room air as driving gas in hypoxic asthma patients; always use oxygen at 6–8 L/min 2
- Do not continue nebulized therapy indefinitely without reassessment; transition to hand-held inhalers within 24–48 hours once stable to permit earlier discharge 1, 3
- Avoid using face masks with ipratropium in elderly patients due to glaucoma risk; use mouthpiece instead 1